Starting
Initialising…
0%
PTEN
Final classification
VUS
PTEN c.431A>C · p.Lys144Thr
PTEN

NM_000314.8:c.431A>C (NP_000305.3:p.Lys144Thr) is a missense variant in exon 5 of PTEN.

Gene
PTEN
Transcript
NM_000314.8
HGVS · transcript:coding
NM_000314.8:c.431A>C
Consequence
N/A
GRCh38
chr10:87933190 A>C
GRCh37
chr10:89692947 A>C
Basis Richards et.al., 2015 - Combining rules v3.2.0 criteria-combination framework was evaluated deterministically with applied criteria: PM2 supporting, PP2 supporting; no rule matched the adjudicated criteria.
Richards et.al., 2015 - Combining rules v3.2.0 criteria-combination framework was evaluated deterministically with applied criteria: PM2 supporting, PP2 supporting; no rule matched the adjudicated criteria.
Classification rationale
PM2PP2 VUS
PTEN c.431A>C

NM_000314.8:c.431A>C (NP_000305.3:p.Lys144Thr) is a missense variant in exon 5 of PTEN. This variant is absent from gnomAD v2.1 and v4.1 (PM2_Supporting per VCEP).1 PTEN has a low rate of benign missense variation and missense variants are a common disease mechanism (PP2_Supporting per VCEP).2 Functional data from Mighell et al. 2018 saturation mutagenesis assay shows a cumulative fitness score of -0.15 for K144T, indicating mild functional impairment that does not meet PS3 or BS3 thresholds.3 REVEL score of 0.691 does not exceed the VCEP PP3 threshold of >0.7; SpliceAI predicts no splice impact.4 The variant lies outside the PTEN catalytic motifs (residues 90-94, 123-130, 166-168); PM1 is not met.5 This variant has been reported in ClinVar as Uncertain Significance (1 submitter, VCV2687516). It has been observed somatically in 3 cancer samples (COSMIC COSV64295211).6 No case-level proband data, de novo observations, co-segregation data, or same-residue pathogenic comparator variants were identified. With 2 supporting-level pathogenic criteria (PM2_Supporting, PP2_Supporting) and no benign criteria met, the variant does not reach the combination threshold for Likely Pathogenic or Pathogenic under the PTEN VCEP v3.2.0 rules. The variant remains a Variant of Uncertain Significance.7

PM2 + PP2 VUS
3 vcep_mmc2
4 revelspliceai ↗
7 cspec ↗final_classification_framework
Gene diagram · NM_000314.8 · variants mapped to exon structure
PTEN NM_000314.8
Fetching transcript structure from UCSC…
Applied criteria · 2 met · select any tile
Met
Not met
Not assessed
N/A
Strength very strong supporting
Pathogenic evidence
PVS
PS
PM
PP
Benign evidence
BA
BS
BP
Rationale
Select a criterion.
Sources
Evidence used
    Gaps remaining
      Rule
      Research & evidence
      Population frequency
      gnomAD v4.1 screenshot
      gnomAD v4.1
      gnomAD v2.1 screenshot
      gnomAD v2.1
      v4.1
      Absent from gnomAD v4.1.
      v2.1
      Absent from gnomAD v2.1.
      🇨🇦 CA
      This variant is absent from gnomAD-Canada.
      Allele frequency by ancestry
      three datasets · side by side
      gnomAD v4.1
      Absent · 0 / ?
      0 hom
      Not observed in any ancestry group.
      gnomAD v2.1
      Absent · 0 / ?
      0 hom
      Not observed in any ancestry group.
      gnomAD Canada 🇨🇦
      Absent · 0 / ?
      0 hom
      Not observed in any ancestry group.
      ClinVar screenshot
      ClinVar
      This variant has been reported in ClinVar as Uncertain significance (1 clinical laboratory). (ClinVarID = 2687516)
      SpliceAI screenshot
      In silico
      SpliceAI predicts no significant splice impact for this variant (max delta score = 0.00). REVEL score = 0.691. BayesDel score = 0.0587913.
      Functional / OncoKB screenshot
      Functional Unknown Oncogenic Effect
      OncoKB did not identify variant-specific reviewed functional evidence for this variant; gene-level curated context is available for reviewer follow-up. PTEN, a lipid and protein phosphatase, is one of the most frequently mutated genes in cancer.
      OncoKB ↗
      COSMIC screenshot
      COSMIC
      Cancer hotspots screenshot
      Cancer hotspots
      Somatic evidence Not in COSMIC / hotspots
      COSMIC
      This variant does not lie in a statistically significant hotspot. This variant has previously been reported in somatic cancers (COSMIC; COSV64295211, n = 3 times).
      Hotspots
      This variant does not lie in a statistically significant hotspot.
      Sources & reference links
      8Sources
      CSpec VCEP
      ClinVar
      gnomAD v2.1
      gnomAD v4.1
      SpliceAI
      OncoKB
      COSMIC
      Cancer hotspots
      Triaged references · 3 PMIDs not cited in assessment
      25394175 ↗ A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. CLINVAR
      31829902 ↗ Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline. CLINVAR
      35924163 ↗ Genetic Testing and Its Clinical Application in Prostate Cancer Management: Consensus Statements from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology. CLINVAR